1. Indian Ministry of health and family welfare, accessed 15-march-2020
2. https://www.cdc.gov/coronavirus/2019-ncov/index.html, accessed 15-march-2020
3. World Health Organization. Coronavirus disease (COVID-2019) situation reports.WHO; 2020. Available from: https://www.who.int/emergencies/diseases/novelcoronavirus-2019/situation-reports, accessed on April 15, 2020.
4. Wearing HJ, Rohani P, Keeling MJ. Appropriate models for the management of infectious diseases. PLoS Med. 2005;2: e174.
5. Lloyd AL. The dependence of viral parameter estimates on the assumed viral life cycle: limitations of studies of viral load data. Proc Biol Sci. 2001; 268:847–54.
6. Sanche S, et al. High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2. Emerg Infect Dis. 2020 Jul [date cited]. Available from: URL: https://doi.org/10.3201/ eid2607.200282
7. World Health Organization. Infection prevention and control of epidemic- and pandemic-prone acute respiratory infections in health care. Geneva: World Health Organization; 2014 Available from: https://apps.who.int/iris/bitstream/handle/10665/112656/ 9789241507134_eng.pdf?sequence=1
8. Liu J, et al. Community transmission of severe acute respiratory syndrome coronavirus 2, Shenzhen, China, 2020. Emerg Infect Dis. Available from: 2020 doi.org/10.3201/eid2606.200239
9. Chan J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020 doi: 10.1016/S0140-6736(20)30154-9
10. Li Q, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020; doi:10.1056/NEJMoa2001316.
11. Huang C, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497–506.
12. Burke RM, et al. Active monitoring of persons exposed to patients with confirmed COVID-19 — United States, January–February 2020. MMWR Morb Mortal Wkly Rep. 2020 doi: 10.15585/mmwr.mm6909e1external icon
13. World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) 16-24 February 2020 [Internet]. Geneva: World Health Organization; 2020 Available from: https://www.who.int/docs/default- source/ coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf
14. Ong SW, et al. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA.2020 Mar 4
15. Mode of transmission of virus. Available from: https:// www.who.int/news-room/commentaries/detail/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations
16. Dr. van Doremalen,et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 N Engl J Med 2020; 382:1564-1567 DOI: 10.1056/NEJMc2004973
17. G. Kampf et al. / Journal of Hospital Infection 104 (2020) 246e251
18. Y.L.A. Kwok et al. Face touching: a frequent habit that has implications for hand hygiene. / American Journal of Infection Control 43 (2015) 112-4
19. David A. Schwartz (2020) An Analysis of 38 Pregnant Women with COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes. Archives of Pathology and Laboratory Medicine In-Press. Available from: URL: https://doi.org/10.5858/arpa.2020-0901-SA
20. Huaping Zhu, et al. Transl Pediatr 2020;9(1):51-60 | Available from: http://dx.doi.org/10.21037/tp.2020.02.06
21. Symptoms of corona virus, Available from: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html
22. Chaolin Huang, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China www.thelancet.com Vol 395 February 15, 2020 https://doi.org/10.1016/ S0140-6736(20)30183-5
23. Loss of sense of smell as marker of COVID-19 infection Available from: www.entuk.org
24. Some corona virus patients show signs of stroke, seizures. Available from: https://www.nytimes.com/2020/04/01/health/ coronavirus-stroke-seizures-confusion.html
25. k.k., Tsang O.T., et al. Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis. 2020
26. Bhadra S., et al. Real-time sequence-validated loop-mediated isothermal amplification assays for detection of Middle East respiratory syndrome coronavirus (MERS-CoV) PLoS One. 2015;10
27. Chan J.F., Choi G.K., Tsang A.K., Tee K.M., Lam H.Y., Yip C.C. Development and evaluation of novel real-time reverse transcription-PCR Assays with locked nucleic acid probes targeting leader sequences of human-pathogenic Coronaviruses. J Clin Microbiol. 2015; 53:2722–2726.
28. Xie X., et al. Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing. Radiology. 2020
29. Ai T., et al. Correlation of chest CT and RT-PCR testing in Coronavirus disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology. 2020
30. Shi H., et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020; 20:425–434
31. Xu X., et al. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2. Eur J Nucl Med Mol Imaging. 2020; 47:1275–1280.
32. Wang Y., et al. Combination of RT-qPCR testing and clinical features for diagnosis of COVID-19 facilitates management of SARS-CoV-2 outbreak. J Med Virol. 2020
33. Pool testing of SARS-CoV-02 samples increases worldwide test capacities many times over/ aktuelles.uni-frankfurt.de/englisch/ pool-testing-of-sars-cov-02-samples-increases-worldwide-test-capacities-many-times-over/
34. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019 published in Clinical Infectious Diseases, ciaa344, available from: https://doi.org/10.1093/ cid/ciaa344
35. Chan JF, et al. Interspecies transmission and emergence of novel viruses: lessons from bats and birds. Trends Microbiol. 2013; 21:544-55
36. Zhu N, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. The New England journal of medicine. 2020
37. Hoffmann M, et al. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. bioRxiv. 2020:2020.01.31.929042.
38. Wrapp D, et al. Cryo-EM structure of the 2019-nCoV spike in the perfusion conformation. Science (New York, NY). 2020.
39. Charalampos Pierrakos, et al. Acute Respiratory Distress Syndrome: Pathophysiology and Therapeutic Options J Clin Med Res 2011; 4(1):7-16
40. Welliver R, et al. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. JAMA 2001; 285: 748–54
41. Yao X, Ye F, Zhang M, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis 2020; published online March 9. DOI:10.1093/cid/ciaa237
42. 42)Hydroxychloroquine usage recommendations by ICMR Available from: https://icmr.nic.in/sites/default/files/ upload_documents/HCQ_Recommendation_22March_final_MM_V2.pdf
43. Existing drugs that may be repurposed to treat coronavirus. Available from: https://www.nbcnews.com/health/health-news/ here-are-some-existing-drugs-may-be-repurposed-treat-coronavirus-n1162021
44. Coronavirus treatment. Available from: https:// theconversation.com/coronavirus-treatments-what-drugs-might-work-against-covid-19-135352
45. B. Cao, et al. A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19, n engl j med march 18, 2020 DOI: 10.1056/NEJMoa2001282
46. Luo P, et al. Tocilizumab treatment in COVID-19: A single center experience. J Med Virol. 2020 Apr 6. doi: 10.1002/jmv.25801
47. The covid-19 vaccine development landscape, available from: https://www.nature.com/articles/d41573-020-00073-5
48. ad5-ncov vaccine moves into phase ii clinical-trials, available from: https://www.trialsitenews.com/chinas-covid-19-vaccine-called-ad5-ncov-moves-into-phase-ii-clinical-trial-500-volunteers-sought/
49. Mair-Jenkins J, et al. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the
50. treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis. 2015; 211:80-90.
51. convalescent-plasma-therapy-for-covid-19. Available from: https://www.thehindu.com/scitech/health/convalescent-plasma-therapy-for-covid-19/article31371149.ece
52. Soo YO, et al. Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients. Clin Microbiol Infect. 2004; 10:676-8
53. Preventive measures for Covid-19 https://www.who.int/health-topics/coronavirus#tab=tab_1
54. Hemila H. Vitamin C intake and susceptibility to pneumonia. Pediatr Infect Dis J. 1997; 16:836-7.